dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes.

scientific article published on 18 January 2016

dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SREP19340
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/srep19340
P932PMC publication ID4726101
P698PubMed publication ID26777304
P5875ResearchGate publication ID291136598

P50authorG. P. S. RaghavaQ58210866
P2093author name stringRahul Kumar
Jagpreet Singh Nanda
P2860cites workEfficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyQ24563021
HMMER web server: interactive sequence similarity searchingQ24603071
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in CancerQ24608391
A decade of exploring the cancer epigenome - biological and translational implicationsQ24614467
Jalview Version 2--a multiple sequence alignment editor and analysis workbenchQ24655519
Multiple sequence alignment with the Clustal series of programsQ24672842
Basic local alignment search toolQ25938991
SUPERFAMILY--sophisticated comparative genomics, data mining, visualization and phylogenyQ26781958
HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignmentQ28256122
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setQ28389579
Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and diseaseQ28396109
Pfam: the protein families databaseQ28660698
The cancer genomeQ29547643
Circos: an information aesthetic for comparative genomicsQ29547653
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityQ29547693
DNA methylation and human diseaseQ29615417
Epigenetics in cancerQ29617139
Comparative protein structure modeling using MODELLERQ29617493
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphomaQ33375600
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaQ33386623
COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell linesQ34079092
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemiaQ36100977
DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modificationsQ36491558
The dynamic epigenome and its implications in toxicologyQ36901377
Cause and consequences of genetic and epigenetic alterations in human cancer.Q37511752
Post-translational modification of cellular proteins by ubiquitin and ubiquitin-like molecules: role in cellular senescence and aging.Q37795745
Epigenetics and the environment: emerging patterns and implicationsQ37972995
Novel and selective inhibitors of histone deacetylase: patent highlightQ39730675
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)19340
P577publication date2016-01-18
P1433published inScientific ReportsQ2261792
P1476titledbEM: A database of epigenetic modifiers curated from cancerous and normal genomes
P478volume6

Reverse relations

cites work (P2860)
Q107112039Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection
Q99562144Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications
Q45943371Computer-aided biomarker discovery for precision medicine: data resources, models and applications.
Q38837677Current situation and future usage of anticancer drug databases
Q60912671Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1
Q47260412EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients
Q38748410Exploring the epigenetic drug discovery landscape
Q41781135Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.
Q47668612Interactions Between Genetics, Lifestyle, and Environmental Factors for Healthcare
Q64101984KMT1 family methyltransferases regulate heterochromatin-nuclear periphery tethering via histone and non-histone protein methylation
Q61811059Long Non-coding RNA in Neuronal Development and Neurological Disorders
Q26748603Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine
Q100430222Recent progress on cheminformatics approaches to epigenetic drug discovery

Search more.